PARIS CEDEX 15
France
37
2025-03-20
19
2024-12-10
These are the the leading inventors for applications assigned to INSTITUT PASTEUR:
INSTITUT PASTEUR based in PARIS CEDEX 15, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
METHODS AND REAGENTS FOR DETECTING PIPERAQUINE-RESISTANT PLASMODIUM FALCIPARUM MALARIA
#2 | 2021-04-08RECOMBINANT MEASLES VIRUSES EXPRESSING EPITOPES OF ANTIGENS OF RNA VIRUSES - USE FOR THE PREPARATION OF VACCINE COMPOSITIONS
#3 | 2021-04-01 â Patent 12,163,150 granted on 2024-12-10Recombinant measles viruses expressing epitopes of antigens of RNA virusesâuse for the preparation of vaccine compositions
#4 | 2020-10-01COMPOUNDS FOR USE IN THE TREATMENT OR PREVENTION OF LOWE SYNDROME OR DENT DISEASE AND METHODS THEREFOR
#5 | 2020-03-26 â Patent 10,793,877 granted on 2020-10-06Recombinant measles viruses expressing epitopes of antigens of RNA virusesâuse for the preparation of vaccine compositions
#6 | 2016-03-17 â Patent 9,868,989 granted on 2018-01-16Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection
#7 | 2016-02-11 â Patent 9,914,937 granted on 2018-03-13Recombinant measles viruses expressing epitopes of antigens of RNA virusesâuse for the preparation of vaccine compositions
#8 | 2015-10-01 â Patent 9,701,944 granted on 2017-07-11Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
#9 | 2014-08-14RECOMBINANT ADENYLATE CYCLASE TOXIN OF BORDETELLA INDUCES T CELL RESPONSES AGAINST TUMORAL ANTIGENS
#10 | 2014-06-05ATTENUATED PLASMODIUM WITH DEACTIVATED HMGB2 GENE, AS VACCINE
#11 | 2014-03-27 â Patent 9,957,555 granted on 2018-05-01Method, probe and kit for DNA in situ hybridization and use thereof
#12 | 2013-06-13 â Patent 9,499,792 granted on 2016-11-22Methods for obtaining stem cells
#13 | 2012-04-26 â Patent 8,822,665 granted on 2014-09-02Neuron generation, regeneration and protection
#14 | 2012-02-16MOLECULAR SIGNATURE OF LIVER TUMOR GRADE AND USE TO EVALUATE PROGNOSIS AND THERAPEUTIC REGIMEN
#15 | 2012-02-09USE OF BASIC PROLIN-RICH LACRIMAL GENE PRODUCTS, SUCH AS OPIORPHIN, AS A BIOMARKER
#16 | 2011-12-22 â Patent 8,980,634 granted on 2015-03-17Reverse genetics of negative-strand RNA viruses in yeast
#17 | 2011-11-03USE OF PHENOL-SOLUBLE MODULINS FOR VACCINE DEVELOPMENT
#18 | 2011-07-21OPIORPHIN FOR USE AS A PSYCHOSTIMULANT AGENT
#19 | 2011-05-26 â Patent 8,889,827 granted on 2014-11-18Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases
#20 | 2011-02-10CXCL12 GAMMA A CHEMOKINE AND USES THEREOF
#21 | 2011-02-03METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF
#22 | 2010-11-25 â Patent 8,367,348 granted on 2013-02-05Upregulation of RACK-1 in melanoma and its use as a marker
#23 | 2010-11-25 â Patent 8,420,104 granted on 2013-04-16Lentiviral gene transfer vectors and their medicinal applications
#24 | 2010-11-04 â Patent 9,023,643 granted on 2015-05-05Medicaments and methods for treating mesothelioma
#25 | 2010-10-28 â Patent 8,404,250 granted on 2013-03-26Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
#26 | 2010-10-28 â Patent 9,657,074 granted on 2017-05-23Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof
#27 | 2010-08-05IDENTIFICATION AND CHARACTERIZATION OF RACEMASES, DEFINITION OF PROTEIN SIGNATURES, AND A TEST FOR DETECTING D-AMINO ACID AND FOR SCREENING MOLECULES CAPABLE OF INHIBITING THE ACTIVITY OF RACEMASE, ESPECIALLY PROLINE RACEMASE
#28 | 2010-04-22NEUROVIRULENT STRAIN OF THE WEST NILE VIRUS AND USES THEREOF
#29 | 2010-03-04POST-TRANSLATIONALLY MODIFIED NEUROTROPHINS
#30 | 2009-10-29 â Patent 7,842,462 granted on 2010-11-30Identification of substances that inhibit NEMO oligomerization
#31 | 2009-06-25 â Patent 8,735,565 granted on 2014-05-27Rapid detection of the âhigh-virulentâ ST-17 clone of group B
#32 | 2009-04-30ACELLULAR IMMUNOGENIC COMPOSITIONS AND ACELLULAR VACCINE COMPOSITIONS AGAINST BACILLUS ANTHRACIS
#33 | 2009-04-16UPREGULATION OF RACK-1 IN MELANOMA AND ITS USE AS A MARKER
#34 | 2008-05-22 â Patent 7,674,578 granted on 2010-03-09Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy
#35 | 2007-05-01 â Patent 7,211,263 granted on 2007-05-01Use of adenylate cyclase or bacteria producing it as vaccines against
#36 | 2006-10-26Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
#37 | 2006-08-17Methionine salvage pathway in Bacillus
Also check out INSTITUT PASTEUR's (Paris Cedex 15, France) applicant profile with 18 patent applications submitted.
26067 â